EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Initial insights into the relationship between symptomatic COVID-19 disease and specific clinical and blood parameters in patients with alcohol use disorder

Lea Kozina, Divna Blažev, Danijela Zakić-Milas, Zrnka Kovačić Petrović

Frontiers in Public Health · 23.04.2026 · 14

DOI: 10.3389/fpubh.2026.1773558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 23.04.2026. Verfasst von Lea Kozina und 3 weiteren Autor:innen. Beteiligte Einrichtung: University Psychiatric Hospital Vrapče, Zagreb, Croatia. Hauptthemen laut MEDLINE: Alcoholism, COVID-19. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with alcohol use disorder (AUD) are at higher risk for long-term Coronavirus Disease 2019 (COVID-19) related consequences, due to bidirectional relationship and shared biological pathways between chronic alcohol use and COVID-19 disease. However, they are significantly underrepresented in the literature examining adverse outcomes associated with COVID-19 disease.

Objective

Therefore, we comprehensively examined the initial group differences between AUD patients who experienced symptomatic COVID-19 disease and AUD patients without a history of COVID-19 disease. We investigated differences between COVID-19 and non-COVID-19 groups in AUD severity (alcohol use, alcohol craving), cognitive functions (assessed by the Montreal Cognitive Assessment), and basic blood parameters.

Methods

This pilot study was conducted in two study points 6 months apart. Participants were 32 COVID-19 AUD patients and 31 non-COVID-19 AUD patients, who met rigorous inclusion and exclusion criteria. Sociodemographic questionnaire, COVID-19 interview and validated measurement instruments (5.0.0. Mini International Neuropsychiatric Interview, M.I.N.I.; Penn Alcohol Craving Scale, PACS; Alcohol Use Disorders Identification Test, AUDIT; Montreal Cognitive Assessment, MoCA; Clinical Institute Withdrawal Assessment for Alcohol Scale, Revised, CIWA-Ar) were assessed. Also, blood parameters were measured: erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) as inflammatory; alanine transaminase (ALT), aspartate transaminase (AST) and gamma-glutamyl transferase (GGT) as biochemical; total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides (TG) as lipid parameters.

Results

In the COVID-19 group, 93.7 % of participants had a mild form of the disease. There was significant difference between the two groups in cognitive functions which improved in the non-COVID-19 group, whereas they remained unchanged in the COVID-19 group [ F (1, 56.157) = 6.875, p = 0.011]. TC showed distinct pattern over time in the COVID-19 group [ F (1, 49.997) = 18.234, p = < 0.001]. CRP showed a weak negative relationship with the time since recovery from COVID-19 ( b = −0.025, p = 0.009). The non-relapse group also showed an improvement in cognitive functions after six months, in contrast to the relapse group [ F (1, 56.157) = 6.879, p = 0.011]. In all participants, HDL levels increased after six months [ F (1, 58.036) = 4.604, p = 0.036].

Conclusions

Cognitive functions and blood parameters require long-term follow-up in COVID-19 AUD patients. Better clinical and blood outcomes in non-relapse group support the overall benefits of reduction in alcohol use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlcoholismCOVID-19HumansFemaleMaleMiddle AgedPilot ProjectsAdultCognitionSeverity of Illness IndexSARS-CoV-2

Stichwörter der Autor:innen

COVID-19alcohol cravingalcohol use disorderblood parameterscognition

Autor:innen und Institutionen

  • University Psychiatric Hospital Vrapče, Zagreb, Croatia.
  • The Institute of Social Sciences Ivo Pilar, Zagreb, Croatia.
  • School of Medicine, University of Zagreb, Zagreb, Croatia.

Zitieren

APA

Kozina, L., Blažev, D., Zakić-Milas, D., & Kovačić Petrović, Z. (2026). Initial insights into the relationship between symptomatic COVID-19 disease and specific clinical and blood parameters in patients with alcohol use disorder. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1773558

Vancouver

Kozina L, Blažev D, Zakić-Milas D, Kovačić Petrović Z. Initial insights into the relationship between symptomatic COVID-19 disease and specific clinical and blood parameters in patients with alcohol use disorder. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1773558

BibTeX
@article{Kozina2026,
  author = {Kozina, Lea and Blažev, Divna and Zakić-Milas, Danijela and Kovačić Petrović, Zrnka},
  title = {Initial insights into the relationship between symptomatic COVID-19 disease and specific clinical and blood parameters in patients with alcohol use disorder},
  journal = {Frontiers in Public Health},
  year = {2026},
  volume = {14},
  doi = {10.3389/fpubh.2026.1773558}
}
Kostenlos starten →